Nevertheless, since MODY2 mutations cause GCK to be hyposensitive rather than insensitive to glucose, most MODY2 patients have mild fasting hyperglycemia and lower chance of complications and they achieve good control over glucose levels for several years with only lifestyle modifications (16). The gene discussed is GCK; the disease is Hyperglycemia.